MRK

SEC source: 0001225208-09-021804 · doc4.xml · derivative · entry 8

KELLEY WILLAM N · CIK 0001204361 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2011-04-26

F4 · price: This option, which vesting on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021804 · doc4.xml · derivative · entry 7

KELLEY WILLAM N · CIK 0001204361 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2014-04-29

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021804 · doc4.xml · derivative · entry 6

KELLEY WILLAM N · CIK 0001204361 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2010-04-27

F4 · price: This option, which vesting on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021804 · doc4.xml · derivative · entry 5

KELLEY WILLAM N · CIK 0001204361 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2013-04-27

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021804 · doc4.xml · derivative · entry 4

KELLEY WILLAM N · CIK 0001204361 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2012-04-25

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021804 · doc4.xml · derivative · entry 3

KELLEY WILLAM N · CIK 0001204361 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,653.6834

Underlying: Common Stock · 52,653.6834 shares

Expires not disclosed

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

SEC source: 0001225208-09-021804 · doc4.xml · nonDerivative · entry 2

KELLEY WILLAM N · CIK 0001204361 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By IRA

Disclosed balance after: 750

F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions").

SEC source: 0001225208-09-021804 · doc4.xml · nonDerivative · entry 1

KELLEY WILLAM N · CIK 0001204361 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,561

F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions").

SEC source: 0001225208-09-021805 · doc4.xml · derivative · entry 3

REPRESAS CARLOS E · CIK 0001216083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2019-04-30

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021805 · doc4.xml · derivative · entry 2

REPRESAS CARLOS E · CIK 0001216083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,651.6274

Underlying: Common Stock · 2,651.6274 shares

Expires not disclosed

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

SEC source: 0001225208-09-021805 · doc4.xml · nonDerivative · entry 1

REPRESAS CARLOS E · CIK 0001216083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions").

SEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 11

SHENK THOMAS E · CIK 0001204362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2019-04-30

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 10

SHENK THOMAS E · CIK 0001204362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2018-04-29

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 9

SHENK THOMAS E · CIK 0001204362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2017-04-26

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 8

SHENK THOMAS E · CIK 0001204362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2016-04-27

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 7

SHENK THOMAS E · CIK 0001204362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2015-04-28

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 6

SHENK THOMAS E · CIK 0001204362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2011-04-26

F4 · price: This option, which vesting on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 5

SHENK THOMAS E · CIK 0001204362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2014-04-29

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 4

SHENK THOMAS E · CIK 0001204362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2013-04-27

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 3

SHENK THOMAS E · CIK 0001204362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2012-04-25

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 2

SHENK THOMAS E · CIK 0001204362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,993.3995

Underlying: Common Stock · 9,993.3995 shares

Expires not disclosed

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

SEC source: 0001225208-09-021806 · doc4.xml · nonDerivative · entry 1

SHENK THOMAS E · CIK 0001204362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions").

SEC source: 0001225208-09-021807 · doc4.xml · derivative · entry 13

TATLOCK ANNE M · CIK 0001020567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2019-04-30

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021807 · doc4.xml · derivative · entry 12

TATLOCK ANNE M · CIK 0001020567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2018-04-29

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021807 · doc4.xml · derivative · entry 11

TATLOCK ANNE M · CIK 0001020567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2017-04-26

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021807 · doc4.xml · derivative · entry 10

TATLOCK ANNE M · CIK 0001020567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2016-04-27

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021807 · doc4.xml · derivative · entry 9

TATLOCK ANNE M · CIK 0001020567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2015-04-28

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021807 · doc4.xml · derivative · entry 8

TATLOCK ANNE M · CIK 0001020567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2011-04-26

F4 · price: This option, which vesting on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021807 · doc4.xml · derivative · entry 7

TATLOCK ANNE M · CIK 0001020567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2014-04-29

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021807 · doc4.xml · derivative · entry 6

TATLOCK ANNE M · CIK 0001020567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2010-04-27

F4 · price: This option, which vesting on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021807 · doc4.xml · derivative · entry 5

TATLOCK ANNE M · CIK 0001020567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2013-04-27

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021807 · doc4.xml · derivative · entry 4

TATLOCK ANNE M · CIK 0001020567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2012-04-25

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021807 · doc4.xml · derivative · entry 3

TATLOCK ANNE M · CIK 0001020567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,089.5897

Underlying: Common Stock · 30,089.5897 shares

Expires not disclosed

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

SEC source: 0001225208-09-021807 · doc4.xml · nonDerivative · entry 2

TATLOCK ANNE M · CIK 0001020567 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 695.9613

F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions").

SEC source: 0001225208-09-021807 · doc4.xml · nonDerivative · entry 1

TATLOCK ANNE M · CIK 0001020567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400

F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions").

SEC source: 0001225208-09-021808 · doc4.xml · derivative · entry 12

THIER SAMUEL O MD · CIK 0001144773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2019-04-30

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021808 · doc4.xml · derivative · entry 11

THIER SAMUEL O MD · CIK 0001144773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2018-04-29

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021808 · doc4.xml · derivative · entry 10

THIER SAMUEL O MD · CIK 0001144773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2017-04-26

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021808 · doc4.xml · derivative · entry 9

THIER SAMUEL O MD · CIK 0001144773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2016-04-27

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021808 · doc4.xml · derivative · entry 8

THIER SAMUEL O MD · CIK 0001144773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2015-04-28

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021808 · doc4.xml · derivative · entry 7

THIER SAMUEL O MD · CIK 0001144773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2011-04-26

F4 · price: This option, which vesting on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021808 · doc4.xml · derivative · entry 6

THIER SAMUEL O MD · CIK 0001144773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2014-04-29

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021808 · doc4.xml · derivative · entry 5

THIER SAMUEL O MD · CIK 0001144773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2010-04-27

F4 · price: This option, which vesting on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021808 · doc4.xml · derivative · entry 4

THIER SAMUEL O MD · CIK 0001144773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2013-04-27

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021808 · doc4.xml · derivative · entry 3

THIER SAMUEL O MD · CIK 0001144773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,275

Underlying: Common Stock · 5,275 shares

Expires 2012-04-25

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021808 · doc4.xml · derivative · entry 2

THIER SAMUEL O MD · CIK 0001144773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,862.8785

Underlying: Common Stock · 37,862.8785 shares

Expires not disclosed

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions.

SEC source: 0001225208-09-021808 · doc4.xml · nonDerivative · entry 1

THIER SAMUEL O MD · CIK 0001144773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20

F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions").

SEC source: 0001225208-09-021809 · doc4.xml · derivative · entry 9

WEEKS WENDELL P · CIK 0001206158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2019-04-30

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021809 · doc4.xml · derivative · entry 8

WEEKS WENDELL P · CIK 0001206158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2018-04-29

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

SEC source: 0001225208-09-021809 · doc4.xml · derivative · entry 7

WEEKS WENDELL P · CIK 0001206158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2017-04-26

F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.